Brain Aging in Very Old Men With Type 2 Diabetes
Open Access
- 1 October 2006
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 29 (10) , 2268-2274
Abstract
OBJECTIVE—Type 2 diabetes leads to cognitive impairment and dementia, which may reflect microvascular and macrovascular complications as well as neurodegenerative processes. There are few studies on the anatomical basis for loss of cognitive function in type 2 diabetes. The objective of this study was to investigate the association between type 2 diabetes and markers of brain aging on magnetic resonance images, including infarcts, lacunes, and white matter hyperintensities as markers of vascular damage and general and hippocampal atrophy as markers of neurodegeneration in Japanese-American men born between 1900 and 1919 and followed since 1965 in the Honolulu-Asia Aging Study. RESEARCH DESIGN AND METHODS—Prevalent and incident dementia was assessed. Associations between magnetic resonance imaging markers and diabetic status were estimated with logistic regression, controlling for sociodemographic and other vascular factors. RESULTS—The prevalence of type 2 diabetes in the cohort is 38%. Subjects with type 2 diabetes had a moderately elevated risk for lacunes (odds ratio [OR] 1.6 [95% CI 1.0–2.6]) and hippocampal atrophy (1.7 [0.9–2.9]). The risk for both hippocampal atrophy and lacunes/infarcts was twice as high in subjects with compared with those without type 2 diabetes. Among the group with type 2 diabetes, those with the longest duration of diabetes, those taking insulin, and those with complications had relatively more pathologic brain changes. CONCLUSIONS—There is evidence that older individuals with type 2 diabetes have an elevated risk for vascular brain damage and neurodegenerative changes. These pathological changes may be the anatomical basis for an increased risk of cognitive impairment or dementia in type 2 diabetes.Keywords
This publication has 44 references indexed in Scilit:
- Insulin, insulin-degrading enzyme and amyloid-β peptide in Alzheimer's disease: review and hypothesisNeurobiology of Aging, 2006
- Midlife Blood Pressure and the Risk of Hippocampal AtrophyHypertension, 2004
- Insulin-degrading Enzyme Rapidly Removes the β-Amyloid Precursor Protein Intracellular Domain (AICD)Journal of Biological Chemistry, 2002
- Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by DegradationJournal of Biological Chemistry, 1998
- Lacunar Infarcts Defined by Magnetic Resonance Imaging of 3660 Elderly People: The Cardiovascular Health StudyArchives of Neurology, 1998
- Hyperinsulinemia and Cardiovascular Disease in Elderly MenArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Clinical Correlates of White Matter Findings on Cranial Magnetic Resonance Imaging of 3301 Elderly PeopleStroke, 1996
- Stroke in the Diabetic PatientDiabetes Care, 1994
- Diabetes and the risk of stroke. The Honolulu Heart ProgramJAMA, 1987
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984